| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |